Condition: Extensive Stage Small Cell Lung Cancer (ES-SCLC) · Sponsor: Gilead Sciences
The goal of this clinical study is to learn more about the study drug sacituzumab govitecan (SG; Trodelvy®; GS-0132; IMMU 132), versus standard of care (SOC) in participants with previously treated extensive stage small cell lung cancer (ES-SCLC). The primary objectives of this study are to compare the effect of SG to SOC on overall survival (OS).
This description comes directly from the study's public registry record.
Gilead Clinical Study Information Cente · 1-833-445-3230 (GILEAD-0) · GileadClinicalTrials@gilead.com
Always discuss trial participation with your own doctor first.
| Genesis Cancer and Blood Institute | Hot Springs, Arkansas, United States | Recruiting |
| Los Angeles Cancer Network | Anaheim, California, United States | Recruiting |
| Boca Raton Regional | Miami, Florida, United States | Recruiting |
| Hope and Healing Cancer Services | Hinsdale, Illinois, United States | Recruiting |
| Southern Illinois University School of Medicine | Springfield, Illinois, United States | Recruiting |
| Springfield Clinic | Springfield, Illinois, United States | Recruiting |
| Parkview Research Center | Fort Wayne, Indiana, United States | Recruiting |
| IU Health Ball Memorial Hospital and Physicians - Cancer Center - Muncie | Muncie, Indiana, United States | Recruiting |
| Northwest Cancer Centers | Dyer, Kentucky, United States | Recruiting |
| St. Claire Regional Medical Ce | Morehead, Kentucky, United States | Recruiting |
| Maine Health Cancer Care | Scarborough, Maine, United States | Not Yet Recruiting |
| Optum Care Cancer Care | Las Vegas, Nevada, United States | Not Yet Recruiting |
+ 206 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06801834